Showing 3211-3220 of 18626 results for "".
Key Insights on Endoscopic Strictures in Crohn’s Disease
https://reachmd.com/programs/gi-insights/key-insights-on-endoscopic-strictures-in-crohns-disease/14626/Find out what the latest guidelines recommend for the treatment of Crohn’s disease strictures.Selenium in Chronic Illness
https://reachmd.com/programs/clinicians-roundtable/selenium-in-chronic-illness/3058/Selenium functions as a dietary antioxidant and may play a role in many chronic diseases. When should we consider selenium augmentation? Dr. Maria Boosalis joins host Dr. Leslie Lundt to discuss this exciting new area of nutritional research.Can Men Increase Their Longevity?
https://reachmd.com/programs/clinicians-roundtable/can-men-increase-their-longevity/2779/Women live longer than men, even in the poorest countries. This statistic from a 2006 article in The British Medical Journal was the topic of our discussion with guest Dr. Ken Brummel-Smith, Professor in the department of Geriatrics at Florida State University College of Medicine. He and host, Dr. BCardiac Implications of an Exercise Prescription
https://reachmd.com/programs/clinicians-roundtable/cardiac-implications-of-an-exercise-prescription/2970/How close are we to tailoring exercise programs to patients based on their level of cardiac health? One study, conducted by Dr. Aaron Baggish, a cardiology fellow at Massachusetts General Hospital and the lead author of research published in the Journal of Applied Physiology, reveals the specific caThe Impact of Stress on Heart Attack Risk and Recovery in Women
https://reachmd.com/programs/primary-care-today/the-impact-of-stress-on-heart-attack-risk-and-recovery-in-women/7303/Stress has long been associated with cardiovascular risk, but few studies have connected stress with worsened recovery rates after heart attacks. Moreover, the recently published discovery that women with mental stress may suffer worse outcomes recovering from heart attacks than men under similar coThe Current Therapeutic Landscape in Unresectable Stage III NSCLC
https://reachmd.com/programs/cme/the-current-therapeutic-landscape-in-unresectable-stage-iii-nsclc/36148/Reimagine lung cancer care—discover how new and emerging therapies are reshaping the treatment of SCLC and NSCLCFrom Silent Killer to Treatable Disease: Improved Detection Methods for Ovarian Cancer
https://reachmd.com/programs/clinicians-roundtable/from-silent-killer-treatable-disease-improved-detection-methods-ovarian-cancer/7929/From the American Cancer Society, ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of the female reproductive system. A woman's risk of getting ovarian cancer during her lifetime is about 1 in 75. Her lifetime chance of dying from ovarian cancDEARA Versus SOC in FSGS Management: Clinical Trial Insights
https://reachmd.com/programs/cme/deara-versus-soc-in-fsgs-management-clinical-trial-insights/37188/FSGS 360°: From Patient Experience to Precision MedicineTelehealth in MS Care: Addressing the Potential for Improvement and Concerns
https://reachmd.com/programs/neurofrontiers/telehealth-in-ms-care-addressing-the-potential-for-improvement-and-concerns/18039/Tune in as we discuss ways to leverage technology to advance access to care for multiple sclerosis patients.Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
https://reachmd.com/programs/neurofrontiers/novel-mechanisms-in-schizophrenia-guidelines/36641/Schizophrenia treatment has long centered on D2 receptor antagonism, but is that still enough? With novel, mechanism-based therapies now available, such as muscarinic agonists, TAAR1 agonists, and glutamate modulators, the case for modernizing current guidelines is growing stronger. Joining Dr. Char